Immunoglobulin Fusion Protein Global Market Report 2025
상품코드:1769621
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
면역글로불린 융합 단백질 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 복합 연간 성장률(CAGR) 13.7%로 성장할 전망이며, 768억 9,000만 달러로 성장이 예측됩니다. 예측 기간에 예상되는 성장은 노인 인구 증가, 융합 단백질을 포함한 임상시험 확대, 맞춤형 의료에 대한 수요 증가, 희귀 질병용 의약품에 대한 규제 당국의 지원, 재택 면역 요법 치료 증가 등에 기인하고 있습니다. 이 기간 주요 동향으로는 피하제제로의 전환, 단백질 설계에서의 AI 통합, 이중특이성 융합 단백질 개발, 제약기업과 바이오테크놀로지 기업의 제휴, 단백질 공학의 진보 등을 들 수 있습니다.
자가면역 질환의 유병률 상승은 향후 면역글로불린 융합 단백질 시장의 성장을 가속할 것으로 예측됩니다. 자가면역 질환은 신체의 면역계가 실수로 자신의 건강한 세포나 조직을 공격하는 질환입니다. 이러한 유병률 증가는 주로 유전적 소인과 환경 요인의 조합에 의해 발생하며, 유전적 유전자는 개인을 더 취약하게 만들고 감염병 및 라이프스타일 등의 유인은 이러한 질환의 발병에 기여합니다. 면역글로불린 융합 단백질은 면역반응을 조절해 염증을 감소시키고 면역계가 신체 조직을 공격하는 것을 막아 자가면역 질환 관리를 돕습니다. 예를 들어 2024년 11월 독일을 거점으로 하는 조직인 Versorgungsatlas.de 의 데이터에 따르면 2022년 7324만 1305명의 피보험자 중 630만 4340명이 최소 1개의 자가면역 질환 진단을 받았고, 생유병률은 8.61%였습니다. 이처럼 자가면역 질환 유병률 증가가 면역글로불린 융합 단백질 시장 확대에 박차를 가하고 있습니다.
면역글로불린 융합 단백질 시장의 주요 기업은 치료 효과의 향상과 복수의 질환 경로를 표적으로 하는 것을 목적으로 한 이중특이성 항체 융합 단백질과 같은 혁신적인 제품을 생산하기 위한 임상시험의 실시에 주력하고 있습니다. 이중특이성 항체 융합 단백질은 두 개의 서로 다른 표적을 동시에 결합할 수 있는 유전공학적으로 설계된 분자로 면역세포를 종양세포에 접근시키거나 여러 질환 경로를 동시에 차단함으로써 표적치료를 강화합니다. 예를 들어 2025년 2월 중국에 본사를 둔 바이오테크놀로지 기업 Innovent Biologics, Inc.는 진행성 고형암을 대상으로 한 이중특이성 항체 융합 단백질 IBI343에 대해 미국 식품의약국(FDA)으로부터 두 번째 패스트 트랙 지정(FTD)을 받았습니다. IBI343은 종양 관련 항원과 면역 이펙터 세포에 동시에 작용하여 항종양 면역 반응의 정확도와 강도를 향상시키도록 설계되었습니다. 이번 지정으로 IBI343의 임상개발과 규제당국의 평가가 가속화돼 암 영역에서 중요한 암메트메디컬 니즈를 충족시킬 가능성이 강조될 것으로 기대됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 면역글로불린 융합 단백질 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 면역글로불린 융합 단백질 시장 : 성장률 분석
세계의 면역글로불린 융합 단백질 시장 실적 : 규모 및 성장(2019-2024)
세계의 면역글로불린 융합 단백질 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 면역글로불린 융합 단백질 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 면역글로불린 융합 단백질 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
단일클론항체
폴리클로날 항체
이중특이적 항체
재조합 항체
세계의 면역글로불린 융합 단백질 시장 : 약제 클래스별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
면역억제제
면역자극제
세계의 면역글로불린 융합 단백질 시장 : 투여 방법별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
정맥내
피하
근육내
세계의 면역글로불린 융합 단백질 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
자가면역 질환
안질환
당뇨병
혈우병
세계의 면역글로불린 융합 단백질 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
연구기관
세계의 면역글로불린 융합 단백질 시장 : 단일클론항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
인간 단일클론항체
인간화 단일클론항체
키메라 단일클론항체
마우스 단일클론항체
세계의 면역글로불린 융합 단백질 시장 : 폴리클로날 항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
동물 유래 폴리클로날 항체
인간 유래 폴리클로날 항체
재조합 폴리클로날 항체
세계의 면역글로불린 융합 단백질 시장 : 이중특이성 항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
탠덤 싱글 체인 가변 조각
이중 가변 도메인 항체
이중특이성 T 세포 인게이저(BiTE)
이중 친화성 재표적화 항체
세계의 면역글로불린 융합 단백질 시장 : 재조합 항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
단편 항체
전장 재조합 항체
항체 약물 복합체(ADC)
변형 항체 도메인
제7장 지역별 및 국가별 분석
세계의 면역글로불린 융합 단백질 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 면역글로불린 융합 단백질 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
면역글로불린 융합 단백질 시장 : 경쟁 구도
면역글로불린 융합 단백질 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer Aktiengesellschaft : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
Bristol-Myers Squibb Company : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Gilead Sciences Inc.
Eli Lilly and Company
Amgen Inc.
Teva Pharmaceutical Industries Limited
Regeneron Pharmaceuticals Inc.
Sobi
3SBio Inc.
Innovent Biologics Inc.
Chengdu Kanghong Pharmaceutical Group Co. Ltd.
Samsung Bioepis Co. Ltd.
Proteintech Group Inc.
KRISHGEN Biosystems
Abnova(Taiwan)Corporation
Celgen Biopharma Inc.
Chimerigen Laboratories LLC
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
면역글로불린 융합 단백질 시장(2029년) : 새로운 기회를 제공하는 국가
면역글로불린 융합 단백질 시장(2029년) : 새로운 기회를 제공하는 부문
면역글로불린 융합 단백질 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
An immunoglobulin fusion protein is a biologically engineered molecule formed by combining the functional domain of a target protein or peptide with the constant region of an immunoglobulin (antibody). This fusion improves the stability, half-life, and solubility of the target protein and can enhance its therapeutic effectiveness by utilizing the immune system's natural processes.
The primary types of immunoglobulin fusion proteins include monoclonal antibodies, polyclonal antibodies, bispecific antibodies, and recombinant antibodies. Monoclonal antibodies are laboratory-engineered proteins designed to specifically target and neutralize particular pathogens by imitating the body's immune response. The drug classes include immunosuppressive and immunostimulatory drugs. These proteins are delivered via different methods such as intravenous, subcutaneous, and intramuscular injections. They are applied in treating various conditions like autoimmune diseases, eye disorders, diabetes, and hemophilia. The main end users consist of hospitals, clinics, and research institutions.
The immunoglobulin fusion protein market research report is one of a series of new reports from The Business Research Company that provides immunoglobulin fusion protein market statistics, including the immunoglobulin fusion protein industry global market size, regional shares, competitors with the immunoglobulin fusion protein market share, detailed immunoglobulin fusion protein market segments, market trends, and opportunities, and any further data you may need to thrive in the immunoglobulin fusion protein industry. This immunoglobulin fusion protein market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The immunoglobulin fusion proteins market size has grown rapidly in recent years. It will grow from $40.39 billion in 2024 to $46.05 billion in 2025 at a compound annual growth rate (CAGR) of 14.0%. The growth during the historic period is due to the rising prevalence of autoimmune diseases, increased adoption of biologics, higher demand for targeted therapies, enhanced diagnostic capabilities, and greater investment in biologics research and development.
The immunoglobulin fusion proteins market size is expected to see rapid growth in the next few years. It will grow to $76.89 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth projected for the forecast period can be attributed to the increasing geriatric population, expansion of clinical trials involving fusion proteins, rising demand for personalized medicine, regulatory support for orphan drugs, and the increase in home-based immunotherapy treatments. Key trends during this period include a shift toward subcutaneous formulations, the integration of AI in protein design, the development of bispecific fusion proteins, collaborations between pharmaceutical and biotech companies, and advancements in protein engineering.
The rising prevalence of autoimmune disorders is anticipated to drive the growth of the immunoglobulin fusion protein market in the future. Autoimmune disorders are conditions where the body's immune system mistakenly attacks its own healthy cells and tissues. This increasing prevalence is mainly caused by a combination of genetic predisposition and environmental factors, with inherited genes making individuals more vulnerable and triggers such as infections or lifestyle contributing to the onset of these diseases. Immunoglobulin fusion proteins assist in managing autoimmune disorders by modulating the immune response to decrease inflammation and prevent the immune system from attacking the body's tissues. For example, in November 2024, data from Versorgungsatlas.de, a Germany-based organization, indicated that in 2022, out of 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, resulting in a raw prevalence rate of 8.61%. Thus, the growing prevalence of autoimmune disorders is fueling the expansion of the immunoglobulin fusion protein market.
Key companies in the immunoglobulin fusion protein market are concentrating on conducting clinical trials to create innovative products like bispecific antibody fusion proteins aimed at improving therapeutic effectiveness and targeting multiple disease pathways. A bispecific antibody fusion protein is a genetically engineered molecule capable of binding two different targets simultaneously, which enhances targeted therapy by bringing immune cells closer to tumor cells or blocking several disease pathways at the same time. For example, in February 2025, Innovent Biologics, Inc., a biotechnology company based in China, received its second Fast Track Designation (FTD) from the U.S. Food and Drug Administration (FDA) for IBI343, a bispecific antibody fusion protein aimed at advanced solid tumors. IBI343 is designed to engage tumor-associated antigens and immune effector cells simultaneously, thereby improving the precision and strength of anti-tumor immune responses. This designation is expected to speed up the clinical development and regulatory evaluation of IBI343, highlighting its potential to meet critical unmet medical needs in oncology.
In April 2023, Yuhan Corporation, a pharmaceutical company based in South Korea, acquired Progen Inc. for an undisclosed sum. Through this acquisition, Yuhan Corporation seeks to improve its expertise in developing multi-target antibody therapeutics and to reinforce both domestic and global partnerships by setting up an Open Innovation Center with Progen. Progen Inc. is a South Korean biotechnology firm specializing in immunoglobulin fusion proteins.
Major players in the immunoglobulin fusion protein market are Pfizer Inc., AbbVie Inc., Bayer Aktiengesellschaft, Sanofi S.A., Bristol-Myers Squibb Company, Gilead Sciences Inc., Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Sobi, 3SBio Inc., Innovent Biologics Inc., Chengdu Kanghong Pharmaceutical Group Co. Ltd., Samsung Bioepis Co. Ltd., Proteintech Group Inc., KRISHGEN Biosystems, Abnova (Taiwan) Corporation, Celgen Biopharma Inc., Chimerigen Laboratories LLC
North America was the largest region in the immunoglobulin fusion proteins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in immunoglobulin fusion protein report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the immunoglobulin fusion protein market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The immunoglobulin fusion protein market consists of sales of etanercept, abatacept, aflibercept, alefacept, and rilonacept. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Immunoglobulin Fusion Protein Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on immunoglobulin fusion protein market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for immunoglobulin fusion protein ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The immunoglobulin fusion protein market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Immunoglobulin Fusion Protein Market Characteristics
3. Immunoglobulin Fusion Protein Market Trends And Strategies
4. Immunoglobulin Fusion Protein Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Immunoglobulin Fusion Protein Growth Analysis And Strategic Analysis Framework
5.1. Global Immunoglobulin Fusion Protein PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Immunoglobulin Fusion Protein Market Growth Rate Analysis
5.4. Global Immunoglobulin Fusion Protein Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Immunoglobulin Fusion Protein Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Immunoglobulin Fusion Protein Total Addressable Market (TAM)
6. Immunoglobulin Fusion Protein Market Segmentation
6.1. Global Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies
Polyclonal Antibodies
Bispecific Antibodies
Recombinant Antibodies
6.2. Global Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunosuppressive Drugs
Immunostimulatory Drugs
6.3. Global Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous
Subcutaneous
Intramuscular
6.4. Global Immunoglobulin Fusion Protein Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autoimmune Disease
Eye Diseases
Diabetes
Hemophilia
6.5. Global Immunoglobulin Fusion Protein Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Research Institutes
6.6. Global Immunoglobulin Fusion Protein Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Human Monoclonal Antibodies
Humanized Monoclonal Antibodies
Chimeric Monoclonal Antibodies
Murine Monoclonal Antibodies
6.7. Global Immunoglobulin Fusion Protein Market, Sub-Segmentation Of Polyclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Animal-Derived Polyclonal Antibodies
Human-Derived Polyclonal Antibodies
Recombinant Polyclonal Antibodies
6.8. Global Immunoglobulin Fusion Protein Market, Sub-Segmentation Of Bispecific Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tandem Single-Chain Variable Fragment
Dual-Variable Domain Antibodies
Bispecific T-Cell Engagers (BiTEs)
Dual-Affinity Re-Targeting Antibodies
6.9. Global Immunoglobulin Fusion Protein Market, Sub-Segmentation Of Recombinant Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fragment Antibodies
Full-Length Recombinant Antibodies
Antibody-Drug Conjugates (ADCs)
Engineered Antibody Domains
7. Immunoglobulin Fusion Protein Market Regional And Country Analysis
7.1. Global Immunoglobulin Fusion Protein Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Immunoglobulin Fusion Protein Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Immunoglobulin Fusion Protein Market
8.1. Asia-Pacific Immunoglobulin Fusion Protein Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Immunoglobulin Fusion Protein Market
9.1. China Immunoglobulin Fusion Protein Market Overview
9.2. China Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Immunoglobulin Fusion Protein Market
10.1. India Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Immunoglobulin Fusion Protein Market
11.1. Japan Immunoglobulin Fusion Protein Market Overview
11.2. Japan Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Immunoglobulin Fusion Protein Market
12.1. Australia Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Immunoglobulin Fusion Protein Market
13.1. Indonesia Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Immunoglobulin Fusion Protein Market
14.1. South Korea Immunoglobulin Fusion Protein Market Overview
14.2. South Korea Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Immunoglobulin Fusion Protein Market
15.1. Western Europe Immunoglobulin Fusion Protein Market Overview
15.2. Western Europe Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Immunoglobulin Fusion Protein Market
16.1. UK Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Immunoglobulin Fusion Protein Market
17.1. Germany Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Immunoglobulin Fusion Protein Market
18.1. France Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Immunoglobulin Fusion Protein Market
19.1. Italy Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Immunoglobulin Fusion Protein Market
20.1. Spain Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Immunoglobulin Fusion Protein Market
21.1. Eastern Europe Immunoglobulin Fusion Protein Market Overview
21.2. Eastern Europe Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Immunoglobulin Fusion Protein Market
22.1. Russia Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Immunoglobulin Fusion Protein Market
23.1. North America Immunoglobulin Fusion Protein Market Overview
23.2. North America Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Immunoglobulin Fusion Protein Market
24.1. USA Immunoglobulin Fusion Protein Market Overview
24.2. USA Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Immunoglobulin Fusion Protein Market
25.1. Canada Immunoglobulin Fusion Protein Market Overview
25.2. Canada Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Immunoglobulin Fusion Protein Market
26.1. South America Immunoglobulin Fusion Protein Market Overview
26.2. South America Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Immunoglobulin Fusion Protein Market
27.1. Brazil Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Immunoglobulin Fusion Protein Market
28.1. Middle East Immunoglobulin Fusion Protein Market Overview
28.2. Middle East Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Immunoglobulin Fusion Protein Market
29.1. Africa Immunoglobulin Fusion Protein Market Overview
29.2. Africa Immunoglobulin Fusion Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Immunoglobulin Fusion Protein Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Immunoglobulin Fusion Protein Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Immunoglobulin Fusion Protein Market Competitive Landscape And Company Profiles
30.1. Immunoglobulin Fusion Protein Market Competitive Landscape
30.2. Immunoglobulin Fusion Protein Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Bayer Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
31. Immunoglobulin Fusion Protein Market Other Major And Innovative Companies
31.1. Gilead Sciences Inc.
31.2. Eli Lilly and Company
31.3. Amgen Inc.
31.4. Teva Pharmaceutical Industries Limited
31.5. Regeneron Pharmaceuticals Inc.
31.6. Sobi
31.7. 3SBio Inc.
31.8. Innovent Biologics Inc.
31.9. Chengdu Kanghong Pharmaceutical Group Co. Ltd.
31.10. Samsung Bioepis Co. Ltd.
31.11. Proteintech Group Inc.
31.12. KRISHGEN Biosystems
31.13. Abnova (Taiwan) Corporation
31.14. Celgen Biopharma Inc.
31.15. Chimerigen Laboratories LLC
32. Global Immunoglobulin Fusion Protein Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Immunoglobulin Fusion Protein Market
34. Recent Developments In The Immunoglobulin Fusion Protein Market
35. Immunoglobulin Fusion Protein Market High Potential Countries, Segments and Strategies
35.1 Immunoglobulin Fusion Protein Market In 2029 - Countries Offering Most New Opportunities
35.2 Immunoglobulin Fusion Protein Market In 2029 - Segments Offering Most New Opportunities
35.3 Immunoglobulin Fusion Protein Market In 2029 - Growth Strategies
